WeedAdvisor

AUGUST 28, 2019

As we reported earlier , marijuana experts were frustrated over the poor quality of cannabis grown at the government’s only legal marijuana facility at the University of Mississippi. Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. Dozens of Applications”. .

DEA 61

DEA Marijuana History THC 61

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

JUNE 16, 2022

NORML’s Political Director Morgan Fox added: “The fact that these interdiction efforts are growing — at great cost to the taxpayer — despite increasing momentum for legalization is a testament to the failure of federal prohibition and unnecessarily burdensome state regulatory policies. million plants were confiscated).

DEA 52

DEA Marijuana Programs Data 52

Veriheal

AUGUST 24, 2022

Colorado could legalize psychedelics. This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. The city of Denver, Colorado, decriminalized the possession and use of psilocybin in 2019—the first U.S.

Legalization 99

Legalization Medicine Decriminalization Research and Development 99

Cannabis Law Report

OCTOBER 4, 2021

However, this drug is not presently legally available, as it is classified as a Schedule I drug, severely restricted and regulated by the federal Controlled Substances Act. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment.

Therapy 52

Therapy Patients Law Clinical Trials 52

Veriheal

SEPTEMBER 13, 2022

The legal cannabis industry in the United States has slowly expanded over the last decade. With legalization, patients and consumers have more freedom in product choice, and many are turning to homegrown cannabis. With legalization, patients and consumers have more freedom in product choice, and many are turning to homegrown cannabis.

Cultivation 108

Cultivation Data DEA Dispensary 108

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin.

Clinical Trials 92

Clinical Trials Research and Development Therapy Policy 92

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. Circuit), a pending petition for review of DEA’s August 2020 Interim Final Rule purportedly implementing the 2018 Farm Bill’s amendments to the CSA.

DEA 111

DEA Hemp Cultivation Advocacy 111

SMPL

AUGUST 14, 2019

The American Bar Association (ABA) adopted a resolution on Monday that calls on Congress to allow states to set their own marijuana policies and recommends rescheduling or descheduling cannabis under federal law. The report goes on to describe how its recommendations would help resolve some of these issues.

Policy 40

Policy Research and Development Marijuana DEA 40

Veriheal

NOVEMBER 11, 2023

Many states in the US have legalized cannabis, thirty-eight states to be exact. According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Is Medical Cannabis Legal? tetrahydrocannabinol (THC) are legal.

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

NOVEMBER 4, 2021

Should President Biden wish to acknowledge the political, economic, and moral realities surrounding cannabis policy, and fulfill the promises he made on the campaign trail, this report lays out a clear roadmap for how to do so.”. We’re beyond that.”. The FDA Director role continues to be unfilled.

DEA 52

DEA Marijuana Decriminalization Data 52

Cannabis Law Report

MAY 29, 2022

In 2020, Oregon became the first locale to decriminalize psilocybin and legalize it for therapeutic use on a statewide basis. 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. and Seattle, among other municipalities. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

FEBRUARY 28, 2022

This Essay analyzes the ethical, legal, and social implications of patenting these controversial substances. Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. Patents on Psychedelics: The Next Legal Battlefront of Drug Development. 19 × 19.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

CannaMD

SEPTEMBER 15, 2020

Either way, it’s important you stay up to date with Florida’s rapidly evolving legal landscape: Can you use medical marijuana at work? What law legalized medical marijuana in Florida? To fully understand this definition, you also need to know two other legal definitions: Medical marijuana treatment center.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

AUGUST 12, 2022

Drug policy topics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. Which Political Party Will Legalize Weed? Mainstreaming Cannabinoids – Path To Legalization.

Research and Development 52

Research and Development Events Topical Policy 52

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. Since then, NORML’s mission has been to shift the public narrative and legalize cannabis. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. Since then, NORML’s mission has been to shift the public narrative and legalize cannabis. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

Cannabis Law Report

JULY 23, 2021

Today, adult use of cannabis, which is classified as a Schedule 1 controlled substance under the Controlled Substances Act (CSA), is legal in 18 states, and the medical use of cannabis is legal in 37 states, though cannabis use remains illegal under federal law. The Draft would also direct the Dep.

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

NOVEMBER 2, 2021

The companies are advertising it as a legal way to get high, touting medical benefits and generally making big promises about what they can deliver, but an investigation from the US Cannabis Council has found illegal levels of delta-9 THC in products for sale around the country. The Legality of Delta-8 THC. What Needs to be Done?

THC 96

THC CBD Legalization Vaping 96

Canna Law Blog

JANUARY 11, 2022

The issue of enforcement or compliance is probably the biggest one most states face at the policy level. The thought process goes that three things will reduce the illicit market: (1) federal and statewide legalization, (2) incentives to access the legal market, and (3) putting compliance ahead of enforcement.

Compliance 77

Compliance Compliance State Laws DEA 77

Veriheal

DECEMBER 27, 2022

Researchers have taken a big step in understanding the connection between using psychedelics and feeling connected to nature in a study published in the journal Drug Science, Policy, and Law on Oct. Study findings indicated that those who had previously taken LSD and psilocybin reported a greater sense of “nature relatedness.”

Research and Development 79

Research and Development Therapy Consumption DEA 79

SpeedWeed

AUGUST 19, 2021

In recent months, a synthetic compound derived from hemp called THC-O acetate—often referred to simply as THC-O (pronounced “THC oh”)—has quickly gained popularity among Americans who don’t have access to legal cannabis. . THC-O products are increasingly popular in states where consumers don’t have access to legal cannabis.

THC 52

THC Hemp Extraction Vaping 52

Cannabis Law Report

JANUARY 13, 2022

In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. 1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. McGuireWoods LLP. Newsworthy Highlights. Happy 2022! Montana: As of Jan. Louisiana: As of Jan.

Dispensary 52

Dispensary Law Concentrates DEA 52

NORML

APRIL 8, 2020

As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. In 2016, the agency appeared to reconsider its longstanding policy, and publicly stated for the first time that it would consider additional applicants.

Cultivation 349

Cultivation DEA Clinical Trials Marijuana 349

SpeedWeed

MARCH 18, 2021

Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. Wasn’t the DEA going to let others grow research-grade cannabis? He has covered the legal cannabis industry since 2010.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Canna Law Blog

MARCH 4, 2020

Still, for all its promise, would-be clinic owners, practitioners, and consumers may be confused about the legality of such clinics. What are the exact legalities behind ketamine? Failure to follow these very specific legal directives can lead to immediate criminal liability under federal law.

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

Canna Law Blog

NOVEMBER 6, 2021

Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. But only if it is made affordable and accessible. cities and the State of Oregon have decriminalized or legalized psilocybin. For two decades, U.S. The first is legislative.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Project CBD

AUGUST 23, 2023

A leading California cannabis industry policy influencer, Devitt is currently Director of Regulatory Affairs at CannaCraft & March and Ash. 7 The argument that anything that can be synthesized from hemp-derived CBD is legal is flat-out wrong. percent on a dry weight basis.” The amount of hemp under cultivation in the U.S.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Veriheal

DECEMBER 21, 2022

The Drug Enforcement Administration (DEA) is now mandated to approve applications to be manufacturers of marijuana-derived, FDA-approved drugs under the bill. Rescheduling cannabis and decriminalizing cannabis do not mean the same thing for federal legalization. The law gives the U.S. Descheduling Cannabis.

Clinical Trials 98

Clinical Trials Marijuana Decriminalization History 98

Cannabis Law Report

SEPTEMBER 1, 2021

This prohibition stands in contrast to the 18 states that have “legalized” recreational cannabis use and the 37 states that have enacted laws regulating cannabis use for medical reasons. This legal “gap” raises a number of challenges for policymakers and market participants, particularly with respect to taxation. Introduction.

Policy 100

Policy Cannabis Treatment Law 100

Veriheal

AUGUST 19, 2022

But times are changing, and leaders are now calling for revamped policies on psilocybin, hemp, and cannabis research for varying reasons. ” Cannabis Research Should Be Based on Real, Accessible Products. The DEA stated that they were starting the process of approving additional cannabis cultivators back in 2016.

Hemp 52

Hemp DEA Access Cultivation 52

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Family physicians have a vested interest in policies that advance and protect the health of their patients and the public. Marijuana Possession for Personal Use. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

APRIL 24, 2019

Federal Legalization – Then What? Let’s think through a couple of scenarios and have a peek at the landscape in a post-legalization world. Federal Legalization – Then What? . “ aBIZinaBOX Inc., CPA’s “ PUBLISHER: CANNABIS LAW REPORT.

Legalization 58

Legalization Collective DEA Banking 58

Cannabis Law Report

JUNE 9, 2021

But even if you’re moving from, say, California to Oregon or within Colorado – states where recreational weed is legal – there are still rules and regulations you need to be aware of if you want to avoid potential felony charges. THC mark, they all fall under the same umbrella of legality or illegality, depending on the area.

Marijuana 66

Marijuana Edibles DEA THC 66

Cannabis Law Report

MAY 28, 2022

Despite progress over the past decade, the cannabis industry still struggles to access a fundamental piece of the U.S. Congress should either legalize cannabis or stop deputizing banks as drug enforcement investigators. To be clear, the existing policy does not ban financial services for the cannabis industry.

Banking 52

Banking State Laws Law DEA 52

Cannabis Law Report

MAY 24, 2022

Facts and Procedural History: The Controlled Substances Act was passed in 1970 and created a single legal framework for regulating substances that are thought to have a high risk of abuse and addiction. The criminalization of marijuana was the result of racially motivated policies, such as the Marijuana Tax Act of 1937.

DEA 52

DEA History Medicine Marijuana 52